Insider trades
Jennifer Jarrett, CEO of Damora Therapeutics DMRA, has filed 1 purchase and 18 sales on the open market. Over the past 12 months that comes to a net sale of $1.9M. The latest trade was on 09/25.
Jennifer Jarrett
Director, President and CEO
- Company
- Damora Therapeutics DMRA
- First filing
- 23/01/25
- Trades
- 52 trades
- Buys / sales
- 1 / 18
- 12-month net buying
- −$1.9M
- Last trade
- 09/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 09/25 | 09/28 | 12,500 sh | $20.23 | $252,875 | +2.5% | |
RCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 21,208 sh2 trades | $22.01avg. | $466,826.28 | −9.9% |
| Open-market sale10b5-1 plan | 25/11/07 | 25/11/12 | 50,291 sh | $18.97 | $954,020.27 | −19.0% | |
RCUS | Open-market sale10b5-1 plan | 25/10/06–25/10/08 | 25/10/08 | 50,292 sh2 trades | $14.92avg. | $750,519.6 | −19.0% |
| Open-market sale10b5-1 plan | 24/03/27 | 24/03/29 | 11,551 sh | $17.55 | $202,720.05 | −5.1% | |
RCUS | Open-market sale10b5-1 plan | 24/03/18 | 24/03/20 | 13,449 sh2 trades | $17.92avg. | $240,941.04 | −5.6% |
RCUS | Open-market sale10b5-1 plan | 24/02/26–24/02/27 | 24/02/28 | 58,625 sh2 trades | $20.09avg. | $1,177,966.55 | −19.6% |
| Open-market sale10b5-1 plan | 23/12/22 | 23/12/26 | 21,521 sh | $17.76 | $382,212.96 | −7.7% | |
| Open-market sale10b5-1 plan | 23/09/22 | 23/09/26 | 21,369 sh | $19.99 | $427,166.31 | −6.6% | |
| Open-market sale10b5-1 plan | 23/07/28 | 23/07/31 | 45,000 sh | $20.25 | $911,250 | −11.8% | |
| Open-market sale10b5-1 plan | 23/06/22 | 23/06/26 | 12,437 sh | $19.12 | $237,795.44 | −3.2% | |
| Open-market sale10b5-1 plan | 23/06/16 | 23/06/16 | 12,563 sh | $19.35 | $243,094.05 | −3.1% | |
| Open-market sale | 23/03/16 | 23/03/20 | 8,729 sh | $16.81 | $146,734.49 | −2.1% | |
RCUS | Open-market sale | 23/01/26–23/01/27 | 23/01/30 | 1,900 sh2 trades | $23.53avg. | $44,700 | −0.5% |
